Viridis Mining and Minerals Limited (VMM) ORDINARY FULLY PAID |
Materials |
$85 |
Colossus PFS Unlocks World-Class Project Economics
|
9 Jul 2025 9:31AM |
$0.515 |
$0.990 |
risen by
92.23%
|
|
VMM - Price-sensitive ASX Announcement
Full Release
Key Points
- Colossus Project PFS demonstrates world-class project economics with high margins and low operating costs.
- The project targets high-grade ionic adsorption clay (IAC) rare earth minerals in Brazil.
- Initial phase focuses on mining and beneficiation, producing monazite concentrate and mixed rare earth carbonate (MREC).
- Scalable modular development plan allows phased expansion to match market demand.
- The PFS anticipates strong financial performance, including rapid payback period and high internal rate of return (IRR).
- Significant exploration upside exists at Colossus, with opportunities to expand resources and extend mine life.
- Environmental, social, and governance (ESG) initiatives include renewable energy use, low water consumption, and community engagement.
- The project is strategically positioned to become a leading non-Chinese supplier of key rare earths required for electric vehicles, wind turbines, and other green technologies.
- Strong support from Brazilian authorities and favorable permitting environment.
- Viridis Mining and Minerals is well-funded to advance Colossus into the next stages of development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Almonty Industries Inc (AII) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$75 |
Suspension from Quotation
|
9 Jul 2025 9:30AM |
$4.950 |
$6.780 |
risen by
36.97%
|
|
AII - Price-sensitive ASX Announcement
Full Release
Key Points
- Almonty Industries Inc. (AII) securities are suspended from quotation as of 5 June 2024.
- The suspension is due to the company's failure to lodge its periodic report by the prescribed deadline.
- The ASX Listing Rules require timely lodgment of periodic reports for continued quotation.
- If Almonty does not lodge the required report within five business days, its securities may be removed from quotation.
- The company may apply for removal from the official list if required.
- The announcement details ASX procedures and consequences for non-compliance with listing rules.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
WEB Travel Group Limited (WEB) ORDINARY FULLY PAID |
Consumer Discretionary |
$1,706 |
Appendix 3Y - Rachel Wiseman
|
9 Jul 2025 9:29AM |
$4.520 |
$4.720 |
risen by
4.42%
|
|
Sunrise Energy Metals Limited (SRL) ORDINARY FULLY PAID |
Materials |
$147 |
Application for quotation of securities - SRL
|
9 Jul 2025 9:25AM |
$1.030 |
$1.260 |
risen by
22.33%
|
|
Vitasora Health Limited (VHL) ORDINARY FULLY PAID |
Health Care |
$48 |
Section 708A Cleansing Notice
|
9 Jul 2025 9:24AM |
$0.029 |
$0.028 |
fallen by
3.45%
|
|
Island Pharmaceuticals Limited (ILA) ORDINARY FULLY PAID |
Health Care |
$38 |
Investor presentation
|
9 Jul 2025 9:22AM |
$0.145 |
$0.155 |
risen by
6.90%
|
|
Vitasora Health Limited (VHL) ORDINARY FULLY PAID |
Health Care |
$48 |
Application for quotation of securities - VHL
|
9 Jul 2025 9:22AM |
$0.029 |
$0.028 |
fallen by
3.45%
|
|
NetLinkz Limited (NET) ORDINARY FULLY PAID |
Information Technology |
$12 |
Kognitive Networks Partners with NET and Securelink Networks
|
9 Jul 2025 9:21AM |
$0.003 |
$0.003 |
fallen by
0%
|
|
Mirrabooka Investments Limited (MIR) ORDINARY FULLY PAID |
Financials |
$741 |
Change of Director's Interest Notice
|
9 Jul 2025 9:20AM |
$3.320 |
$3.330 |
risen by
0.30%
|
|
Anatara Lifesciences Ltd (ANR) ORDINARY FULLY PAID |
Health Care |
$1 |
Company Update
|
9 Jul 2025 9:19AM |
$0.006 |
$0.006 |
fallen by
0%
|
|
ANR - Price-sensitive ASX Announcement
Full Release
Key Points
- Anatara Lifesciences Ltd is developing gastrointestinal health products for human and animal markets.
- The company’s key products are GaRP (for human health) and 3FLEX (for animal health).
- Multiple pre-clinical and non-clinical studies have shown promising results.
- The company is actively pursuing regulatory submissions and commercial partnerships.
- Cash reserves and a lean cost structure place Anatara in a stable financial position to execute its strategy.
- ANR is focused on progressing licensing deals and market entry for both its human and animal health products.
- Strategic priorities include advancing regulatory approvals, expanding commercial relationships, and maximizing shareholder value.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
WEB Travel Group Limited (WEB) ORDINARY FULLY PAID |
Consumer Discretionary |
$1,706 |
Becoming a substantial holder
|
9 Jul 2025 9:19AM |
$4.520 |
$4.720 |
risen by
4.42%
|
|
Vitasora Health Limited (VHL) ORDINARY FULLY PAID |
Health Care |
$48 |
Application for quotation of securities - VHL
|
9 Jul 2025 9:19AM |
$0.029 |
$0.028 |
fallen by
3.45%
|
|
Graincorp Limited (GNC) ORDINARY FULLY PAID CLASS A |
Consumer Staple |
$1,707 |
Update - Notification of buy-back - GNC
|
9 Jul 2025 9:17AM |
$7.560 |
$7.680 |
risen by
1.59%
|
|
Island Pharmaceuticals Limited (ILA) ORDINARY FULLY PAID |
Health Care |
$38 |
Portfolio expansion achieved with acquisition of Galidesivir
|
9 Jul 2025 9:16AM |
$0.145 |
$0.155 |
risen by
6.90%
|
|
ILA - Price-sensitive ASX Announcement
Full Release
Key Points
- Island Pharmaceuticals Limited acquired Galidesivir from BioCryst Pharmaceuticals.
- Galidesivir is a broad-spectrum antiviral with potential applications against multiple viral infections.
- The acquisition aligns with Island's strategy to expand its antiviral portfolio, especially targeting mosquito-borne diseases.
- Strategic rationale includes portfolio diversification, increased pipeline value, and enhanced market position in infectious disease therapeutics.
- The addition of Galidesivir is anticipated to provide new opportunities for clinical development and commercialization.
- The transaction underscores Island’s commitment to addressing global health challenges with innovative antiviral solutions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Native Mineral Resources Holdings Limited (NMR) ORDINARY FULLY PAID |
Materials |
$157 |
Investor Presentation
|
9 Jul 2025 9:15AM |
$0.183 |
$0.160 |
fallen by
12.33%
|
|
Kingsland Minerals Ltd (KNG) ORDINARY FULLY PAID |
Materials |
$11 |
Test work underway for rutile & gallium by-product potential
|
9 Jul 2025 9:15AM |
$0.079 |
$0.150 |
risen by
89.87%
|
|
KNG - Price-sensitive ASX Announcement
Full Release
Key Points
- Kingsland Minerals Ltd is conducting test work for rutile and gallium by-product potential at the Leliyn Graphite Project.
- ALS Metallurgy has been engaged for mineralogical and metallurgical studies on recent drill samples.
- Test work aims to assess the presence and recovery of rutile and gallium, which are classified as critical minerals.
- Positive results could add significant value to the graphite project.
- There is strong global demand for both rutile and gallium due to their strategic applications.
- Graphite resource and metallurgical studies are continuing in parallel to the by-product investigations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Sparc Technologies Limited (SPN) ORDINARY FULLY PAID |
Materials |
$18 |
Quarterly activities and cashflow report
|
9 Jul 2025 9:14AM |
$0.160 |
$0.155 |
fallen by
3.13%
|
|
SPN - Price-sensitive ASX Announcement
Full Release
Key Points
- Commissioning and operation of the SPN pilot plant with initial SPN production.
- Progress towards customer qualification and engagement with offtake partners for SPN.
- Advancements in graphene additives business, including environmentally friendly coatings development.
- Receipt of grant funding to support further research and product development.
- Summary of cash outflows and a positive cash position at the end of the quarter.
- Strategic focus on stakeholder engagement and advancing commercial discussions.
- Outlining the company's pathway and objectives for the next quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Native Mineral Resources Holdings Limited (NMR) ORDINARY FULLY PAID |
Materials |
$157 |
Proposed issue of securities - NMR
|
9 Jul 2025 9:12AM |
$0.183 |
$0.160 |
fallen by
12.33%
|
|
Native Mineral Resources Holdings Limited (NMR) ORDINARY FULLY PAID |
Materials |
$157 |
$10M Share Placement for Blackjack Gold Production Ramp-Up
|
9 Jul 2025 9:12AM |
$0.183 |
$0.160 |
fallen by
12.33%
|
|
NMR - Price-sensitive ASX Announcement
Full Release
Key Points
- NMR has announced a $10 million share placement to fund the ramp-up of gold production at the Blackjack Gold Project.
- The placement was strongly supported by institutional and sophisticated investors, resulting in approximately 222.2 million new fully paid ordinary shares to be issued at $0.045 per share.
- The funds raised will primarily be used for mine development, plant upgrades, working capital, and associated costs to ramp up gold production.
- Blackjack Gold Project is located in North Queensland, Australia, and is a key asset for NMR's growth strategy.
- The placement strengthens NMR’s balance sheet and positions the company for accelerated development of the Blackjack Project.
- NMR’s management considers the placement a significant endorsement of its strategy and resource potential.
- The company has set clear milestones for the use of proceeds, including commencing gold production ramp-up activities and advancing exploration at adjacent targets.
- The placement is not subject to shareholder approval, with settlement expected within days of the announcement.
- Directors and management are participating in the placement alongside external investors, further demonstrating confidence in the project.
- NMR has also provided an update on the status of permitting, plant refurbishment, and expected production timelines for the Blackjack Gold Project.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Strickland Metals Limited (STK) ORDINARY FULLY PAID |
Materials |
$373 |
Further High-Grade Gold Intercepts at Gradina
|
9 Jul 2025 9:12AM |
$0.145 |
$0.165 |
risen by
13.79%
|
|
STK - Price-sensitive ASX Announcement
Full Release
Key Points
- Strickland Metals Limited reported additional high-grade gold intercepts at Gradina.
- Recent drilling has resulted in multiple significant gold mineralization intersections.
- The results reinforce the potential for a large and high-quality gold system at Gradina.
- Future exploration will focus on systematic drilling to further define mineralization.
- The announcement underscores Gradina’s role in the company’s growth strategy.
- Upcoming activities will aim to support resource estimation and further discoveries.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
American Rare Earths Limited (ARR) ORDINARY FULLY PAID |
Materials |
$178 |
Strong Leach Recoveries and Low Impurities
|
9 Jul 2025 9:11AM |
$0.235 |
$0.350 |
risen by
48.94%
|
|
ARR - Price-sensitive ASX Announcement
Full Release
Key Points
- High TREO recoveries up to 82% achieved with hydrochloric acid leaching at the Halleck Creek project.
- Metallurgical testwork demonstrates consistent leach performance across various ore types.
- Low levels of impurities and radioactive elements found in product solutions.
- Results support a simplified and potentially lower-cost processing flowsheet.
- Strong leach recoveries and low impurities de-risk the Halleck Creek project.
- Findings align with ARR's strategy to develop a sustainable U.S. rare earth supply chain.
- Testwork strengthens the economic and environmental profile of the project.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Blackstone Minerals Limited (BSX) ORDINARY FULLY PAID |
Materials |
$125 |
High Grade Cu-Au at Surface Delivers New Targets at Mankayan
|
9 Jul 2025 9:09AM |
$0.073 |
$0.074 |
risen by
1.37%
|
|
BSX - Price-sensitive ASX Announcement
Full Release
Key Points
- Significant high-grade copper-gold mineralization identified at surface at the Mankayan Project.
- Channel and rock chip sampling returned grades up to 8.15% copper and 3.63g/t gold.
- Results confirm the potential for both open pit and underground resource development.
- Exploration work has expanded the mineralized footprint and generated new targets.
- Additional drilling and geophysical surveys are planned to refine exploration and development strategies.
- Strong geological evidence supports the potential for an economically viable resource.
- The company is focused on advancing the project towards resource delineation and potential development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
BMG Resources Limited (BMG) ORDINARY FULLY PAID |
Materials |
$6 |
Trading Halt
|
9 Jul 2025 9:08AM |
$0.010 |
$0.007 |
fallen by
30%
|
|
BMG - Price-sensitive ASX Announcement
Full Release
Key Points
- BMG Resources Limited requested a trading halt from the ASX effective 14 April 2022.
- The trading halt is in relation to a proposed capital raising.
- The company seeks to ensure trading occurs on a fully informed basis.
- The trading halt will remain until either an announcement is made or trading resumes on 19 April 2022.
- The company is acting in compliance with ASX Listing Rule requirements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Evergreen Lithium Limited (EG1) ORDINARY FULLY PAID |
Materials |
$8 |
EG1 commences exploration at Leonora Goldfields Project, WA
|
9 Jul 2025 9:08AM |
$0.032 |
$0.033 |
risen by
3.13%
|
|
APA Group (APA) FULLY PAID UNITS STAPLED SECURITIES |
Utilities |
$10,840 |
APA finalises project agreements with CS Energy
|
9 Jul 2025 9:07AM |
$8.340 |
$8.310 |
fallen by
0.36%
|
|